Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial
Year: 2023
Type: erratum
Source: Alzheimer s Research & Therapy
Authors: Bruno Dubois, Jesús López‑Arrieta, Stanley Lipschitz, Triantafyllos Doskas, Luiza Spiru, Svitlana Moroz, Olena Venger, Patrick Vermersch, Alain Moussy, Colin D. Mansfield, Olivier Hermine, Magda Tsolaki, for the AB09004 Study Group Investigators
Institutions: Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Carol Davila University of Medicine and Pharmacy, Fundatia "Ana Aslan" International, I.Horbachevsky Ternopil National Medical University, Inserm, Université de Lille, Centre Hospitalier Universitaire de Lille, Lille Neurosciences & Cognition, AB Science (France), Hôpital Necker-Enfants Malades, Université Paris Cité, Institut des Maladies Génétiques Imagine, Aristotle University of Thessaloniki
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,690
OpenAlex ID: W4366769918